tm logo
NEUVAX
Live/Registered
REGISTERED

on 18 Jan 2022

Last Applicant/ Owned by

7 Times Square, Suite 2503

New York

NY

10036

Serial Number

87878311 filed on 16th Apr 2018

Registration Number

6622822 registered on 18th Jan 2022

in the Principal Register

Correspondent Address

Neil C. Jones

NELSON MULLINS RILEY & SCARBOROUGH LLP

301 South College Street

Suite 2300, IP Department

CHARLOTTE, NC 28202

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

NEUVAX

Pharmaceutical preparations and vaccines for the treatment of cancer

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations and vaccines for the treatment of cancer


First Use Date in General

31st Dec 2015

First Use Date in Commerce

31st Dec 2015

Mark Details


Serial Number

No 87878311

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 038407/09029

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
18th Jan 2022REGISTERED-PRINCIPAL REGISTER
11th Dec 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10th Dec 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
27th Oct 2021STATEMENT OF USE PROCESSING COMPLETE
21st Oct 2021USE AMENDMENT FILED
21st Oct 2021TEAS STATEMENT OF USE RECEIVED
28th Apr 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
27th Apr 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
27th Apr 2021EXTENSION 5 GRANTED
13th Apr 2021EXTENSION 5 FILED